STOCKHOLM, Oct. 4, 2017 /PRNewswire/ -- The earlier announced acquisitions of Medicover Healthcare Private Limited "Medicover Fertility India" and the 22% shareholding of Sahrudaya Healthcare Private Limited "MaxCure", both located in India, are now completed. The transactions were cash settled for € 18.5 million.
From 1 October 2017, Medicover Fertility's results and financial position will be consolidated and the holding in Maxcure will be accounted for as an associated company.
For further information, please contact:
Corporate Communications & Investor Relations, Director
Phone: +46-73-66 6599
This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 10.30 CET on 4 October, 2017.
This information was brought to you by Cision http://news.cision.com
The following files are available for download: